Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesBispecific T-Cell Engaging Antibodies for Cancer Therapy
Cancer Research, 06/18/09
Baeuerle PA et al. - Recent results from clinical studies with a CD19/CD3-bispecific BiTE antibody suggest that this therapeutic paradigm is finally showing promise for treatment of both bulky and minimal residual disease.
Related Articles
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09
Relevance Score: 70%
Hormone Therapy Can Help Some with Prostate Cancer
MedLinePlus, 11/04/09
Relevance Score: 70%
Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09
Relevance Score: 70%
Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy
Breast Cancer Research and Treatment, 10/12/09
Relevance Score: 70%
Radiation Therapy Technique Successfully Treats Pain In Patients With Advanced Cancer
ScienceDaily, 11/04/09
Relevance Score: 69%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Mutiny on the Boun-T: Controlling Dangerous T Cells Through Anergy
Discovery Medicine, 12/17/09
Immunolocalization and mRNA Expression of Bone Morphogenetic Protein-6 in Human Clear Cell Renal Carcinoma
Kidney and Blood Pressure Research, 12/17/09
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
Breast Cancer Research and Treatment, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor